Reports

The following include reports from NCI-supported Clinical Trials Planning Meetings (CTPM), publications based on the work of Scientific Steering Committees, and strategic working groups.

Steering Committee Publications and Meeting Reports
Working Group Reports - Clinical Trials
Working Group Reports - Translational Research
Other Related Reports

Steering Committee Publications and Meeting Reports

• Breast Cancer

  • BCSC HER2 Clinical Trial Planning Meeting, May 14-15, 2012
  • BCSC HER2 Clinical Trial Planning Meeting, May 16-17, 2011
    

  Gastrointestinal Cancer

  • Colon and Rectal Cancers CTPM, January 7-8, 2011
  • Neuroendocrine Tumor, January, 2011
  • Gastrointestinal Stromal Tumors, April 16, 2009
  • Hepatocellular Carcinoma (HCC), December 12-13, 2008
  • Pancreatic Cancer, November 30 - December 1, 2007
    

  Gynecological Cancer

  • Enhancing Clinical Trials in Ovarian Cancer - May 2011
  • Consensus Statement on Clinical Trials in Ovarian Cancer - May 2011
  • Endometrial Cancer State of the Science, January 19, 2009
  • Cervical Cancer, September 27-28, 2007
  • Endometrial Cancer, November 28-29, 2006
    

  Head & Neck Cancer

  • Head and Neck Squamous Cell Cancer and the Human Papillomavirus, November 9-10, 2008

• Investigational Drug Steering Committee (IDSC)

  • IDSC Publication Listing, June 21, 2010
  • IDSC Publication Listing, May 18, 2010
  • Public Summary, Clinical Trial Design TF Recommendations for Phase 2 Clinical Trial Design, July 24, 2009
  • Novel Designs and End Points for Phase II Clinical Trials Meeting Summary, Jan 7, 2007

• Symptom Management and Quality of Life

  • Cancer-related Fatigue, April 13-14, 2010
  • Chemotherapy-induced Peripheral Neuropathy and Power Point, March 23, 2009
    
    

  ---

  Working Group Reports - Clinical Trials

  Clinical Trials Working Group (CTWG)

  • Report of the Clinical Trials Working Group of the National Cancer Advisory Board, Restructuring the National Cancer Clinical Trials Enterprise, June 2005

  The following reports describe strategies to implement CTWG recommendations:

  Guidelines Harmonization Working Group (GHWG)

  • Guidelines Harmonization Working Group Report, July 2009
  • Progress Report on NCI Implementation of the Guidelines Harmonization Working Group Report, December 2010

  Cost-Effectiveness Analysis (CEA) Working Group

  • Recommendations for the Evaluation and Prioritization of Cost-Effectiveness Analyses (CEA) paired with NCI-Sponsored Treatment Trials and a Funding Mechanism for Supporting CEA, September 2010

  Operational Efficiency Working Group (OEWG)

  • Report of the Operational Efficiency Working Group of the Clinical Trials and Translational Research Advisory Committee, March 2010

  CTWG Evaluation Working Group

  • CTWG Evaluation Working Group Final Report

  ---

  Working Group Reports - Translational Research

  Translational Research Working Group (TRWG)

  • Report of the Translational Research Working Group of the National Cancer Advisory Board, Transforming Translation, Harnessing Discovery for Patient and Public Benefit, June 2007

  The following reports describe strategies to implement TRWG recommendations:

  Immune Response Modifier Pathway Prioritization Working Group (IRMP WG)

  • Report of the Immune Response Modifier Pathway Prioritization Working Group, November 2009

  Process to Accelerate Translational Science (PATS) Working Group

  • NCI Process to Accelerate Translational Science (PATS) Working Group Report, Final Report, September 2010

  ---

  Other Related Reports

  Institute of Medicine (IOM)

  • A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program

  AACI-NCI Clinical Trials Reporting Program (CTRP) Strategic Subcommittee

  • AACI-NCI CTRP Strategic Subcommittee Report, July 2011